Back
Lifecore Biomedical 10K Form
Sell
39
LFCR
Lifecore Biomedical
Last Price:
5.99
Seasonality Move:
1.22%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive LFCR News And Ratings
See the #1 stock for the next 7 days that we like better than LFCR
LFCR Financial Statistics
Sales & Book Value
Annual Sales: | $128.26M |
---|---|
Cash Flow: | $-4.04M |
Price / Cash Flow: | 0 |
Annual Sales: | $-0.13 |
Price / Book: | 0 |
Profitability
EPS (TTM): | 0.05000 |
---|---|
Net Income (TTM): | $6.54M |
Gross Margin: | $41.85M |
Return on Equity: | 252.9% |
Return on Assets: | 2.64% |
Lifecore Biomedical Earnings Forecast
Key Lifecore Biomedical Financial Ratios
- The Gross Profit Margin over the past 29 years for LFCR is 32.63%.
- The Selling, General & Administrative Expenses for LFCR have been equal to 31.55% of Gross Profit Margin.
- The Research & Development expenses have been 6.69% of Revenue.
- The Interest Expense is 150.59% of Operating Income.
- The Net Earning history of LFCR is 9.37% of Total Revenues.
- Per Share Earnings over the last 29 years have been positive in 15 years.
Lifecore Biomedical Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Life Sciences Tools & Services |
Sector: | Health Care |
Current Symbol: | LFCR |
Website: | lifecore.com |
Debt
Debt-to-Equity Ratio: | -32.48 |
---|---|
Current Ratio: | 1.83 |
Quick Ratio: | 0.76 |
Price-to-Earnings
Trailing P/E Ratio: | 18.69 |
---|---|
Forward P/E Ratio: | 0 |
LFCR Technical Analysis vs Fundamental Analysis
Sell
39
Lifecore Biomedical (LFCR)
is a Sell
Is Lifecore Biomedical a Buy or a Sell?
-
Lifecore Biomedical stock is rated a Sell
The current Lifecore Biomedical [LFCR] share price is $5.98. The Score for LFCR is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.